Therapeutics: Androgen receptor; MAP kinase interacting serine-threonine kinase 1 (MKNK1; MNK1); MNK2

Cell culture and mouse studies have identified C-4 heteroaryl 13-cis retinamide-based inhibitors of MNK and androgen receptor that could help treat breast and prostate cancers. Chemical synthesis and ...